Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Briacell Therapeutics Corp BCTXW


Primary Symbol: T.BCT Alternate Symbol(s):  BCTX

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.


TSX:BCT - Post by User

Post by Goldnboy1on Oct 05, 2021 2:05am
342 Views
Post# 33965645

29.83

29.83

This is how many shares you would get of $APC for every one share of $BCT.

One and only post. Just spreading the love. Not a spammer. Just a serially successful VC tossing you guys some early stage goodness!

$APC news today. Check it out. Zeglis Labratory trial results selected for oral presentation tomorrow after market close at the World Molecular Imaging Congress. The WMIC is the global leasing medical conference for this field of study.

Selections for presentation are merit based. This is not a conference where you can pay to present. Pretty big deal. Very large community of scientists and doctors that will view the presentation.

Never know what could be inspired from this level of exposure. Be it stock movement and or additional collaborations with who knows who.

The inventor of Kadcyla was hired to run $APC's chemotherapy/radiology programs just a few months ago. Kadcyla does $1B+/Year in sales and was acquired by Roche.  

People like this don't go to work for a hobby. I hear he see's something in the patent portfolio he wants to seriously monetize. 

At the current market cap if he starts executing we are in for a wild ride at $apc and yes like Briacell. I think that future may include a Nasdaq listing once the stock is mature enough.

Some serious USA connections in $APC. Doctors educated from Harvard, Columbia, Yale and Tufts Universities. All Ivey league with a deep history of medical breakthrough.

Won't respond to negaviity. Take this as an olive branch from me to you. This won't be a $11.7M stock for long. 

Stay tuned..!
 

GLTA! 

<< Previous
Bullboard Posts
Next >>